Juno Therapeutics (JUNO) – Momentum Movers
-
Juno Therapeutics (JUNO) Surges 26% as FDA Removes Clinical Hold; Shares Remain Below Pre-Hold Level
-
Juno Therapeutics (JUNO) Will Resume JCAR015 Phase 2 in r/r ALL
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to JUNO Stock Lookup